You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Hydralazine hydrochloride - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for hydralazine hydrochloride and what is the scope of patent protection?

Hydralazine hydrochloride is the generic ingredient in twenty-eight branded drugs marketed by Novartis, Abraxis Pharm, Am Regent, Beowulf Asset, Eugia Pharma, Fresenius Kabi Usa, Hikma, Mylan Institutional, Navinta Llc, Rising, Smith And Nephew, Solopak, Teva Parenteral, Teva, Actavis Elizabeth, Actavis Grp Ptc, Alkem Labs Ltd, Anda Repository, Ascot, Cadila Pharms Ltd, Chartwell Rx, Glenmark Pharms Ltd, Halsey, Heritage Pharms, Heritage Pharms Inc, Hetero Labs Ltd Iii, Impax Labs, Invagen Pharms, Ivax Sub Teva Pharms, Mutual Pharm, Mylan, Pliva, Purepac Pharm, Quantum Pharmics, Sciegen Pharms Inc, Strides Pharma, Superpharm, Upsher Smith Labs, Usl Pharma, Vangard, Vitarine, Watson Labs, West Ward, Solvay, Ivax Pharms, Sandoz, Sun Pharm Industries, Lederle, Azurity, I3 Pharms, and Riconpharma Llc, and is included in one hundred and twenty-four NDAs. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for hydralazine hydrochloride. Forty suppliers are listed for this compound.

Drug Prices for hydralazine hydrochloride

See drug prices for hydralazine hydrochloride

Recent Clinical Trials for hydralazine hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Institute for Medical Research Development (NIMAD), IranPhase 3
McMaster UniversityPhase 3
Shahid Sadoughi University of Medical Sciences and Health ServicesPhase 3

See all hydralazine hydrochloride clinical trials

Pharmacology for hydralazine hydrochloride
Drug ClassArteriolar Vasodilator
Physiological EffectArteriolar Vasodilation
Medical Subject Heading (MeSH) Categories for hydralazine hydrochloride

US Patents and Regulatory Information for hydralazine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis APRESOLINE hydralazine hydrochloride TABLET;ORAL 008303-004 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Ascot HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride TABLET;ORAL 088310-001 Dec 19, 1984 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Actavis Elizabeth HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride TABLET;ORAL 088560-001 Oct 4, 1984 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Ivax Sub Teva Pharms HYDROSERPINE PLUS (R-H-H) hydralazine hydrochloride; hydrochlorothiazide; reserpine TABLET;ORAL 083877-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Quantum Pharmics HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride TABLET;ORAL 088657-001 Jun 15, 1984 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Strides Pharma HYDRA-ZIDE hydralazine hydrochloride; hydrochlorothiazide CAPSULE;ORAL 088946-001 Oct 21, 1985 RX No Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Strides Pharma HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride TABLET;ORAL 200770-002 May 3, 2013 AA RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.